关于 "Aurora Kinase" 的结果23+ 个结果
筛选:MAPK Signaling×
- Tpl2 Kinase InhibitorCAS: 871307-18-5
Tpl2 Kinase Inhibitor（TKI）是一种可透过细胞膜的萘啶化合物，作为Tpl2激酶强效可逆的，ATP竞争性的抑制剂。
- Comprehensive Kinase Screening Library
For screening of a variety of kinase inhibitors
- A-3 hydrochlorideCAS: 78957-85-4
A-3 hydrochloride, a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases, againsts cAMP-dependent protein kinase (PKA) (Ki=4.3 ?M), casein kinase II (CK2) (Ki=5.1 ?M) and myosin light chain kinase (MLCK) (Ki=7.4 ?M), also inhibits Protein Kinase C (PKC) and casein kinase I (CK1) with Ki values of 47 ?M and 80 ?M, respectively.
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC17828 | BI-847325 | 1207293-36-4 | Other Apoptosis | ||
A selective dual MEK/Aurora kinase inhibitor | |||||
| GC43624 | ERK Inhibitor | 1049738-54-6 | MAPK Signaling | ||
An ERK inhibitor | |||||
| GC45067 | Tpl2 Kinase Inhibitor | 871307-18-5 | MAP3K | ||
Tpl2 Kinase Inhibitor（TKI）是一种可透过细胞膜的萘啶化合物，作为Tpl2激酶强效可逆的，ATP竞争性的抑制剂。 | |||||
| GC49150 | Tpl2 Kinase Inhibitor (hydrochloride) | - | Innate Immunity | ||
A Tpl2 inhibitor | |||||
| GC44530 | p38 MAPK Inhibitor | 219138-24-6 | p38 | ||
A potent inhibitor of p38 MAP kinase | |||||
| GC15525 | cGMP Dependent Kinase Inhibitor Peptide | 82801-73-8 | PKA | ||
A cGMP-dependent protein kinase inhibitor | |||||
| GC46123 | Comprehensive Kinase Screening Library | - | Signaling Pathways | ||
For screening of a variety of kinase inhibitors | |||||
| GC18602 | p38 MAPK Inhibitor IV | 1638-41-1 | Innate Immunity | ||
An inhibitor of p38 MAP kinases | |||||
| GC10010 | AS601245 | 345987-15-7 | JNK | ||
AS601245是一种强效的ATP竞争性JNK抑制剂，对JNK1、JNK2和JNK3的IC50值分别为0.15µM、0.22µM和0.07µM。 | |||||
| GC10403 | EO 1428 | 321351-00-2 | p38 | ||
An inhibitor of p38α and p38β MAP kinases | |||||
| GC41740 | (S)-p38 MAPK Inhibitor III | 581098-48-8 | Innate Immunity | ||
A cell-permeable p38 MAP kinase inhibitor | |||||
| GC48329 | PKA Inhibitor (5-24) (trifluoroacetate salt) | - | cAMP | ||
A synthetic peptide inhibitor of PKA | |||||
| GC12904 | BI 78D3 | 883065-90-5 | JNK | ||
A competitive inhibitor of JNK | |||||
| GC13116 | JX 401 | 349087-34-9 | p38 | ||
A potent, reversible inhibitor of p38α MAPK | |||||
| GC12799 | H-8 (hydrochloride) | 113276-94-1 | PKA | ||
A potent, nonspecific kinase inhibitor | |||||
| GC16499 | Sorafenib Tosylate | 475207-59-1 | Other Apoptosis | ||
A multi-kinase inhibitor | |||||
| GC17346 | KT 5823 | 126643-37-6 | Other Apoptosis | ||
Potent selective inhibitor of cGMP-dependent protein kinase (PKG) | |||||
| GC15296 | ML 786 dihydrochloride | 1237536-18-3 | Raf | ||
Raf kinase inhibitor | |||||
| GC60037 | A-3 hydrochloride | 78957-85-4 | PKA | ||
A-3 hydrochloride, a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases, againsts cAMP-dependent protein kinase (PKA) (Ki=4.3 ?M), casein kinase II (CK2) (Ki=5.1 ?M) and myosin light chain kinase (MLCK) (Ki=7.4 ?M), also inhibits Protein Kinase C (PKC) and casein kinase I (CK1) with Ki values of 47 ?M and 80 ?M, respectively. | |||||
| GC19091 | CCT196969 | 1163719-56-9 | Raf | ||
A multi-kinase inhibitor | |||||
| GC40054 | CCT241161 | 1163719-91-2 | MAPK Signaling | ||
A multi-kinase inhibitor | |||||
| GC37522 | RGB-286638 | 784210-87-3 | JAK | ||
A multi-kinase inhibitor | |||||
| GC37523 | RGB-286638 free base | 784210-88-4 | JAK | ||
A multi-kinase inhibitor | |||||